A new small molecule could treat and prevent excess bone formation. Fibrodysplasia ossificans progressiva (FOP) is an extremely rare disease estimated to affect about one in 2 million people worldwide ...
Researchers uncover a redox-regulated mechanism that determines whether bone fractures heal or progress to nonunion ...
Heterotopic ossification (HO), atypical bone formation, causes chronic pain, affecting patient’s quality of life. It occurs ...
A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has developed a promising new therapeutic strategy for fibrodysplasia ossificans ...
Bone regeneration research has taken a significant leap forward with the discovery of a crucial mechanism that could transform treatments for bone disorders. Scientists have identified how Discoidin ...
News Medical on MSN
Study reveals how two key proteins contribute to abnormal bone growth after injury
After serious injuries, burns, fractures, or major surgeries, the body normally repairs damaged tissues and restores movement. However, in some patients, the healing process takes an unexpected and ...
FOP is a disease in which muscles, tendons and ligaments are progressively replaced by bone, leading to eventual incapacitation Garetosmab is the first and only treatment to demonstrate a dramatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results